Household Contact Tracing With Intensified Tuberculosis and Human Immunodeficiency Virus Screening in South Africa: A Cluster-Randomized Trial
Background
Household contact tracing for tuberculosis (TB) may facilitate diagnosis and access to TB preventive treatment (TPT). We investigated whether household contact tracing and intensive TB/human immunodeficiency virus (HIV) screening would improve TB-free survival.
Methods
Household contacts of index TB patients in 2 South African provinces were randomized to home tracing and intensive HIV/TB screening or standard of care (SOC; clinic referral letters). The primary outcome was incident TB or death at 15 months. Secondary outcomes included tuberculin skin test (TST) positivity in children ≤14 years and undiagnosed HIV.
Results
From December 2016 through March 2019, 1032 index patients (4459 contacts) and 1030 (4129 contacts) were randomized to the intervention and SOC arms. Of intervention arm contacts, 3.2% (69 of 2166) had prevalent microbiologically confirmed TB. At 15 months, the cumulative incidence of TB or death did not differ between the intensive screening (93 of 3230, 2.9%) and SOC (80 of 2600, 3.1%) arms (hazard ratio, 0.90; 95% confidence interval [CI], .66–1.24). TST positivity was higher in the intensive screening arm (38 of 845, 4.5%) compared with the SOC arm (15 of 800, 1.9%; odds ratio, 2.25; 95% CI, 1.07–4.72). Undiagnosed HIV was similar between arms (41 of 3185, 1.3% vs 32 of 2543, 1.3%; odds ratio, 1.02; 95% CI, .64–1.64).
Conclusions
Household contact tracing with intensive screening and referral did not reduce incident TB or death. Providing referral letters to household contacts of index patients is an alternative strategy to home visits.
Clinical Trials Registration
ISRCTN16006202.
Top-30
Journals
|
1
2
|
|
|
BMC Global and Public Health
2 publications, 12.5%
|
|
|
PLOS Global Public Health
2 publications, 12.5%
|
|
|
PLoS Medicine
1 publication, 6.25%
|
|
|
Implementation Science Communications
1 publication, 6.25%
|
|
|
BMC Infectious Diseases
1 publication, 6.25%
|
|
|
Clinical Infectious Diseases
1 publication, 6.25%
|
|
|
Research square
1 publication, 6.25%
|
|
|
BMC Public Health
1 publication, 6.25%
|
|
|
Tropical Medicine and International Health
1 publication, 6.25%
|
|
|
JMIR mHealth and uHealth
1 publication, 6.25%
|
|
|
Drugs
1 publication, 6.25%
|
|
|
PLoS ONE
1 publication, 6.25%
|
|
|
BMJ Open
1 publication, 6.25%
|
|
|
JMIR Formative Research
1 publication, 6.25%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
|
|
|
Springer Nature
6 publications, 37.5%
|
|
|
Public Library of Science (PLoS)
4 publications, 25%
|
|
|
JMIR Publications
2 publications, 12.5%
|
|
|
Oxford University Press
1 publication, 6.25%
|
|
|
Wiley
1 publication, 6.25%
|
|
|
BMJ
1 publication, 6.25%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.